Park National Corp’s Pfizer PFE Stock Holding History

Park National Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.83M	Buy	242,081 +186,053	+332%	+$4.87M	0.16%	100
2026 Q1	$1.57M	Sell	56,028 -881	-2%	-$23.5K	0.05%	175
2025 Q4	$1.42M	Sell	56,909 -2,587	-4%	-$65.2K	0.04%	163
2025 Q3	$1.52M	Sell	59,496 -2,315	-4%	-$57.1K	0.05%	156
2025 Q2	$1.5M	Buy	61,811 +2,260	+4%	+$52.7K	0.05%	155
2025 Q1	$1.51M	Sell	59,551 -24,741	-29%	-$647K	0.06%	149
2024 Q4	$2.24M	Sell	84,292 -22,365	-21%	-$607K	0.08%	123
2024 Q3	$3.09M	Sell	106,657 -96,407	-47%	-$2.81M	0.11%	116
2024 Q2	$5.68M	Sell	203,064 -243,513	-55%	-$6.7M	0.21%	84
2024 Q1	$12.4M	Sell	446,577 -23,764	-5%	-$659K	0.48%	60
2023 Q4	$13.5M	Buy	470,341 +22,762	+5%	+$688K	0.55%	53
2023 Q3	$14.8M	Buy	447,579 +2,760	+0.6%	+$97.6K	0.67%	48
2023 Q2	$16.3M	Sell	444,819 -2,033	-0.5%	-$79.1K	0.71%	49
2023 Q1	$18.2M	Buy	446,852 +12,417	+3%	+$536K	0.81%	40
2022 Q4	$22.3M	Sell	434,435 -8,316	-2%	-$399K	0.99%	33
2022 Q3	$19.4M	Buy	442,751 +28,700	+7%	+$1.39M	0.97%	31
2022 Q2	$21.7M	Sell	414,051 -4,231	-1%	-$216K	1.04%	27
2022 Q1	$21.7M	Buy	418,282 +8,562	+2%	+$444K	0.9%	34
2021 Q4	$24.2M	Sell	409,720 -19,060	-4%	-$944K	0.94%	31
2021 Q3	$18.4M	Sell	428,780 -55,702	-11%	-$2.47M	0.78%	40
2021 Q2	$19M	Buy	484,482 +386	+0.1%	+$15K	0.8%	38
2021 Q1	$17.5M	Buy	484,096 +5,020	+1%	+$178K	0.77%	40
2020 Q4	$17.6M	Sell	479,076 -17,388	-4%	-$638K	0.83%	39
2020 Q3	$17.3M	Buy	496,464 +670	+0.1%	+$23.5K	0.91%	33
2020 Q2	$15.4M	Sell	495,794 -510	-0.1%	-$17.3K	0.86%	38
2020 Q1	$15.4M	Buy	496,304 +32,560	+7%	+$1.11M	0.97%	29
2019 Q4	$17.2M	Buy	463,744 +40,117	+9%	+$1.43M	0.88%	38
2019 Q3	$14.4M	Buy	423,627 +157,444	+59%	+$5.73M	0.79%	39
2019 Q2	$10.9M	Buy	266,183 +57,592	+28%	+$2.29M	0.59%	46
2019 Q1	$8.4M	Sell	208,591 -7,863	-4%	-$315K	0.47%	51
2018 Q4	$8.96M	Sell	216,454 -2,605	-1%	-$108K	0.56%	44
2018 Q3	$9.16M	Sell	219,059 -5,473	-2%	-$211K	0.5%	48
2018 Q2	$7.73M	Sell	224,532 -12,015	-5%	-$411K	0.44%	50
2018 Q1	$7.96M	Sell	236,547 -56,953	-19%	-$1.96M	0.46%	52
2017 Q4	$10.1M	Sell	293,500 -23,932	-8%	-$816K	0.56%	47
2017 Q3	$10.8M	Sell	317,432 -19,783	-6%	-$636K	0.62%	43
2017 Q2	$10.7M	Sell	337,215 -19,052	-5%	-$601K	0.64%	43
2017 Q1	$11.6M	Sell	356,267 -29,072	-8%	-$917K	0.7%	41
2016 Q4	$11.9M	Sell	385,339 -10,209	-3%	-$312K	0.72%	40
2016 Q3	$12.7M	Buy	395,548 +5,439	+1%	+$182K	0.81%	38
2016 Q2	$13M	Sell	390,109 -5,485	-1%	-$175K	0.83%	38
2016 Q1	$11.1M	Sell	395,594 -52,755	-12%	-$1.51M	0.74%	42
2015 Q4	$13.7M	Sell	448,349 -22,550	-5%	-$709K	0.93%	33
2015 Q3	$14M	Sell	470,899 -4,735	-1%	-$152K	1.01%	32
2015 Q2	$15.1M	Sell	475,634 -6,978	-1%	-$227K	1.04%	31
2015 Q1	$15.9M	Sell	482,612 -1,339	-0.3%	-$42.6K	1.08%	30
2014 Q4	$14.3M	Buy	483,951 +40,820	+9%	+$1.17M	0.95%	30
2014 Q3	$12.4M	Buy	443,131 +6,431	+1%	+$180K	0.9%	33
2014 Q2	$12.3M	Buy	436,700 +7,809	+2%	+$223K	0.84%	34
2014 Q1	$13.1M	Sell	428,891 -1,214	-0.3%	-$36.2K	0.93%	30
2013 Q4	$12.5M	Sell	430,105 -22,725	-5%	-$661K	0.89%	33
2013 Q3	$12.3M	Sell	452,830 -1,884	-0.4%	-$51.3K	0.94%	30
2013 Q2	$12.1M	Buy	+454,714	New	+$12.6M	0.98%	25

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Park National Corp's PFE Position: Q2 2026 in Review

Park National Corp increased its Pfizer (PFE) stake by 332% in Q2 2026, buying an estimated $4.87M and bringing the position to 242,081 shares worth $5.83M. The position accounts for 0.16% of the portfolio, ranked #100.

Park National Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.2M in Q4 2021. 1,262 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Park National Corp held 242,081 shares of Pfizer worth $5.83M as of Q2 2026.
Park National Corp bought 186,053 Pfizer shares in Q2 2026, an estimated $4.87M.
Pfizer made up 0.16% of Park National Corp's portfolio in Q2 2026, its #100 holding.
Park National Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Park National Corp's Pfizer position peaked at $24.2M in Q4 2021.
1,262 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.